Piramal Pharma Limited

NSEI:PPLPHARMA Lagerbericht

Marktkapitalisierung: ₹389.2b

Piramal Pharma Management

Management Kriterienprüfungen 1/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführerno data
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managementskeine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder3.8yrs

Jüngste Management Updates

Recent updates

₹284 - That's What Analysts Think Piramal Pharma Limited (NSE:PPLPHARMA) Is Worth After These Results

Oct 26
₹284 - That's What Analysts Think Piramal Pharma Limited (NSE:PPLPHARMA) Is Worth After These Results

Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt

Oct 25
Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt

Here's Why Piramal Pharma (NSE:PPLPHARMA) Has A Meaningful Debt Burden

Jul 14
Here's Why Piramal Pharma (NSE:PPLPHARMA) Has A Meaningful Debt Burden

Estimating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Jun 17
Estimating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

We Think That There Are Issues Underlying Piramal Pharma's (NSE:PPLPHARMA) Earnings

May 21
We Think That There Are Issues Underlying Piramal Pharma's (NSE:PPLPHARMA) Earnings

It's A Story Of Risk Vs Reward With Piramal Pharma Limited (NSE:PPLPHARMA)

Mar 26
It's A Story Of Risk Vs Reward With Piramal Pharma Limited (NSE:PPLPHARMA)

Estimating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Feb 28
Estimating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Earnings Update: Here's Why Analysts Just Lifted Their Piramal Pharma Limited (NSE:PPLPHARMA) Price Target To ₹161

Feb 02
Earnings Update: Here's Why Analysts Just Lifted Their Piramal Pharma Limited (NSE:PPLPHARMA) Price Target To ₹161

Calculating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Nov 09
Calculating The Intrinsic Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Calculating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Aug 11
Calculating The Fair Value Of Piramal Pharma Limited (NSE:PPLPHARMA)

Geschäftsführer

Piramal Pharma hat keinen Geschäftsführer, oder es liegen keine verfügbaren Daten vor.

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Nandini Piramal
Executive Chairperson4.7yrs₹42.02m0.13%
₹ 513.7m
Vivek Valsaraj
President2.8yrs₹24.77mkeine Daten
Peter DeYoung
CEO of Piramal Global Pharma & Director4.7yrs₹42.40m0.033%
₹ 126.8m
Neeraj Bharadwaj
Non-Executive Director4.1yrskeine Datenkeine Daten
Subramanian Ramadorai
Independent Non-Executive Director3.8yrs₹4.35m0.0020%
₹ 7.8m
Sridhar Gorthi
Independent Non-Executive Director2.7yrs₹4.20mkeine Daten
Vibha Rishi
Independent Non-Executive Director2.3yrs₹4.25mkeine Daten
Peter Stevenson
Independent Non-Executive Additional Director2.7yrs₹3.80mkeine Daten
Jairaj Purandare
Independent Non Executive Director3.8yrs₹4.55mkeine Daten

3.8yrs

Durchschnittliche Betriebszugehörigkeit

58yo

Durchschnittliches Alter

Erfahrener Vorstand: PPLPHARMADie Vorstandsmitglieder gelten als erfahren (3.8 Jahre durchschnittliche Amtszeit).